STOCK TITAN

Dermata Therapeutics Inc (DRMA) Net Income by Year

DRMA

Dermata Therapeutics Inc reported a net loss of $7.6M in fiscal year 2025. This represents an increase of 38.5% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Dermata Therapeutics Inc has filed alongside them.

FY2025 annual
Net Income -$7.6M
YoY +38.5%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

DRMA Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-K
Net Income-$7.6M+38.5%-$12.3M-57.6%-$7.8M+18.9%-$9.6M-21.6%-$7.9MN/A

DRMA Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$3.0M-74.4%-$1.8M+19.8%N/A-$1.7M+46.7%-$1.7M+39.9%-$2.3M+26.5%N/A-$3.2M-84.6%-$2.8M-66.3%-$3.1M-39.9%N/A-$1.7M+29.1%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Dermata Therapeutics Inc financials

Frequently Asked Questions

What was Dermata Therapeutics Inc's net income in fiscal year 2025?

Dermata Therapeutics Inc reported a net loss of $7.6M in fiscal year 2025.

How fast is Dermata Therapeutics Inc's net income growing?

Dermata Therapeutics Inc (DRMA) net income rose by 38.5% year over year, from -$12.3M to -$7.6M in fiscal year 2025.

What was Dermata Therapeutics Inc's net income in the most recent quarter?

Dermata Therapeutics Inc (DRMA) reported -$3.0M in net income in Q2 2026. This represents a decrease of 74.4% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Dermata Therapeutics Inc (DRMA) reported on that line in every period on record.